bioRxiv · 19 Nov 2026
Evolutionarily conserved coupling of lysosomal response sensing and disease-associated microglial reprogramming scales with pathological timescales
Y. Liang, H. Yuan, Y. Zhao, L. Guo, J. Wang, L. Liyi, Y. Zhang
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Background Microglia transition into disease-associated microglia (DAM) during central nervous system (CNS) injury and neurodegeneration, yet the upstream intracellular logic driving this state conversion in vivo remains unclear. The lysosome acts as a signaling hub, but whether physiological phagocytic load universally initiates and quantitatively couples to DAM reprogramming across different pathological timescales is unknown. Methods We established a rigorous, unit-corrected analytical framework to overcome pseudo-replication in public single-cell data, anchoring statistical inferences at the level of independent biological units (animals, sequencing plates, or donors). We integrated six transcriptomic datasets spanning three murine injury/amyloidosis models and three large-scale human neurodegenerative cohorts (>320,000 microglial nuclei), alongside human Alzheimer's disease (AD) GWAS summary statistics. Results We demonstrate that the MiT/TFE-regulated lysosomal biogenesis program temporally precedes DAM reprogramming and maintains an evolutionarily conserved baseline coupling even in uninjured homeostatic tissue. In human microglia, MITF and TFE3 transcripts closely track DAM activation, whereas post-translationally regulated TFEB mRNA does not. Genetic enrichment analysis (MAGMA) reveals that common AD risk does not act upon the upstream lysosomal program, but is strongly anchored downstream at APOE. Furthermore, Trem2-knockout models demonstrate that disease-induced coupling amplification retains roughly half its magnitude even when the mature DAM subpopulation collapses. Cross-system comparisons reveal a state-transition synchrony model: disease-driven amplification of lysosomal-DAM coupling ({Delta}) scales with pathological timescales, showing strong amplification in acute murine injury and aggressive amyloidosis (5xFAD {Delta} = +0.252), but manifesting primarily as steady baseline maintenance across decades-long asynchronous human AD progression (SEA-AD {Delta} = +0.072). Conclusions Our study establishes the lysosomal stress-DAM coupling as an evolutionarily conserved pacemaking module for microglial state transitions, providing a quantitative framework for therapeutically targeting neuroinflammation and tissue repair.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.